These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38965373)

  • 1. Podocyte injury in extreme obesity.
    Tsuboi N; Okabayashi Y; Haruhara K
    Int J Obes (Lond); 2024 Jul; ():. PubMed ID: 38965373
    [No Abstract]   [Full Text] [Related]  

  • 2. CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy.
    Zhao J; Rui HL; Yang M; Sun LJ; Dong HR; Cheng H
    Mediators Inflamm; 2019; 2019():3172647. PubMed ID: 31097920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy.
    Cui W; Maimaitiyiming H; Zhou Q; Norman H; Zhou C; Wang S
    Biochim Biophys Acta; 2015 Jul; 1852(7):1323-33. PubMed ID: 25835637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased urine podocyte-associated messenger RNAs in severe obesity are evidence of podocyte injury.
    Pereira SV; Dos Santos M; Rodrigues PG; do Nascimento JF; Timm JR; Zancan R; Friedman R; Veronese FV
    Obesity (Silver Spring); 2015 Aug; 23(8):1643-9. PubMed ID: 26147062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early podocyte injury and elevated levels of urinary podocyte-derived extracellular vesicles in swine with metabolic syndrome: role of podocyte mitochondria.
    Zhang LH; Zhu XY; Eirin A; Nargesi AA; Woollard JR; Santelli A; Sun IO; Textor SC; Lerman LO
    Am J Physiol Renal Physiol; 2019 Jul; 317(7):F12-F22. PubMed ID: 31042059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol alleviates obesity-associated podocyte injury in ovariectomized obese rats.
    Li B; Xiao X; Miao Y; Guo L; Zhen J; Li X; Jiang B; Hu Z
    Exp Ther Med; 2020 Jan; 19(1):123-130. PubMed ID: 31853281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of podocyte injury and implications for diabetic nephropathy.
    Barutta F; Bellini S; Gruden G
    Clin Sci (Lond); 2022 Apr; 136(7):493-520. PubMed ID: 35415751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-calorie diet results in reversible obesity-related glomerulopathy in adult zebrafish regardless of dietary fat.
    Zeitler EM; Jennette JC; Flythe JE; Falk RJ; Poulton JS
    Am J Physiol Renal Physiol; 2022 May; 322(5):F527-F539. PubMed ID: 35224994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
    Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
    Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in Podocyte Injury in Diabetic Nephropathy.
    Ishii H; Kaneko S; Yanai K; Aomatsu A; Hirai K; Ookawara S; Ishibashi K; Morishita Y
    Front Genet; 2020; 11():993. PubMed ID: 33193581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte NLRP3 Inflammasome Activation and Formation by Adipokine Visfatin.
    Koka S; Xia M; Zhang C; Zhang Y; Li PL; Boini KM
    Cell Physiol Biochem; 2019; 53(2):355-365. PubMed ID: 31385664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission.
    Chen Z; An X; Liu X; Qi J; Ding D; Zhao M; Duan S; Huang Z; Zhang C; Wu L; Zhang B; Zhang A; Yuan Y; Xing C
    Oncotarget; 2017 Oct; 8(51):88792-88803. PubMed ID: 29179476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease.
    Sun Y; Cui S; Hou Y; Yi F
    Kidney Dis (Basel); 2021 Nov; 7(6):438-451. PubMed ID: 34901191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Traditional Chinese Medicine for Treatment of Podocyte Injury.
    Yao T; Su W; Han S; Lu Y; Xu Y; Chen M; Wang Y
    Front Pharmacol; 2022; 13():816025. PubMed ID: 35281899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through angiopoietin-like protein 4.
    Shen X; Weng C; Wang Y; Wang C; Feng S; Li X; Li H; Jiang H; Wang H; Chen J
    Genes Dis; 2022 Mar; 9(2):443-455. PubMed ID: 35224159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of PTEN in puromycin aminonucleoside-induced podocyte injury.
    Ren Q; Yu S; Zeng H; Xia H
    Int J Med Sci; 2022; 19(9):1451-1459. PubMed ID: 36035365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis.
    Lv F; He Y; Xu H; Li Y; Han L; Yan L; Lang H; Zhao Y; Zhao Z; Qi Y
    Cell Death Dis; 2022 Aug; 13(8):729. PubMed ID: 35999224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects.
    Li X; Zhang Y; Xing X; Li M; Liu Y; Xu A; Zhang J
    Biomed Pharmacother; 2023 Dec; 168():115670. PubMed ID: 37837883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.